Mapping large numbers of results may take a few moments.
Search Results
Showing 151 - 200 of 472 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Eldec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. | Location Durham |
| |
Company Eli Lilly and Company (Durham) | Activity: Production and Manufacturing | Company Description Lilly specializes in drug product formulation, filling and inspection of syringes and building and packaging of auto-injectors at its RTP site | Location Durham |
| |
Company Elo Life Systems Inc. | Activity: Research and Development | Company Description Elo Life Systems uses a platform of precision breeding technologies to produce crops with novel traits. | Location Durham |
| |
Company Elysia Creative Biology | Activity: Research and Development | Company Description Elysia Creative Biology has developed cattle feed that reduces methane emissions. | Location Raleigh |
| |
Company Emergo Therapeutics Inc. | Activity: Research and Development | Company Description Emergo Therapeutics develops drugs to reduce the production of inflammatory cytokines from mast cells and improve the functioning of the immune system in various potential indications, starting with infectious diseases. | Location Durham |
| |
Company Encoded Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Encoded is developing and commercializing gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. | Location Morrisville |
| |
Company Endacea Diagnostics Inc. | Activity: Research and Development | Company Description Endacea Diagnostics is developing EndaTox IVD, an in vitro sepsis diagnostic, and EndaTox Test, an assay to measure LPS endotoxin in biological and non-biological samples. | Location Research Triangle Park |
| |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park |
| |
Company Enfuego Therapeutics Inc. | Activity: Research and Development | Company Description Enfuego Therapeutics is developing novel RNA interference-(RNAi)-based and antisense oligo therapeutics. | Location Morrisville |
| |
Company Entegrion Inc. | Activity: Research and Development | Company Description Entegrion offers a novel point of care in vitro diagnostic blood coagulation monitoring system for use in human and veterinary medicine. | Location Durham |
| |
Company ENTEX Technologies Inc. | Activity: Research and Development | Company Description ENTEX Technologies provides advanced biological and filtration wastewater treatment that can be customized for various industries. | Location Chapel Hill |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company EnviroFlight LLC | Activity: Research and Development | Company Description EnviroFlight provides dried black soldier fly larvae products as a source of sustainable alternative protein. | Location Apex |
| |
Company Envu | Activity: Research and Development | Company Description Envu develops and markets pest-, weed- and disease-control products for non-agricultural areas such as vector control, professional pest management, industrial vegetation management, forestry and turf and ornamentals. | Location Cary |
| |
Company Enzerna Biosciences Inc. | Activity: Research and Development | Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. | Location Morrisville |
| |
Company EpiCypher Inc. | Activity: Research and Development | Company Description EpiCypher develops and manufactures novel products and services for epigenetics and chromatin biology, focused on enabling drug discovery research and development. | Location Durham |
| |
Company Epigenos Biosciences Inc. | Activity: Research and Development | Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage site-specific DNA binding technologies to treat disease at the root of gene mis-regulation. | Location Morrisville |
| |
Company Eppin Pharma Inc. | Activity: Research and Development | Company Description Eppin Pharma is developing a non-hormonal male oral contraceptive. | Location Durham |
| |
Company ER Therapeutics LLC | Activity: Research and Development | Company Description ER Therapeutics is developing and commercializing therapeutics for cancer. | Location Chapel Hill |
| |
Company Essential Pharmaceuticals LLC | Activity: Research and Development | Company Description Essential Pharmaceuticals sells organ preservation solutions. | Location Durham |
| |
Company EternaTear Inc. | Activity: Research and Development | Company Description EternaTear had developed a novel artificial tear formulation that provides long lasting ocular lubrication to offer relief from dry eye. | Location Raleigh |
| |
Company Evecxia Inc. | Activity: Research and Development | Company Description Evecxia is developing drugs which amplify serotonin synthesis to treat neuropsychiatric conditions for which current therapies are inadequate. | Location Research Triangle Park |
| |
Company Extrel Therapeutics Inc. | Activity: Research and Development | Company Description Extrel Therapeutics is developing medical devices to protect patients from post-operative infection, pain and inflammation. | Location Raleigh |
| |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham |
| |
Company Eyedesis Biosciences LLC | Activity: Research and Development | Company Description Eyedesis Biosciences is developing a small-molecule macrophage inhibitor for the treatment of neovascular age related macular degeneration. | Location Chapel Hill |
| |
Company FafaBiotic LLC | Activity: Research and Development | Company Description Fafabiotic develops bioformulations for topical and ingestible probiotics for human health. Fafabiotic also offers consulting services on various aspects of biological product development, from feasibility and technology evaluation to scale-up and readiness for commercialization. | Location Cary |
| |
Company Fair Products Inc. | Activity: Production and Manufacturing | Company Description Fair Products manufactures and distributes tobacco crop care products including insecticides, sucker control, ripeners and fertilizers. | Location Cary |
| |
Company FastBack Bio LLC | Activity: Research and Development | Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. | Location Raleigh |
| |
Company Fennec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Fennec Pharmaceuticals develops a sodium thiosulfate formula for the prevention of ototoxicity from cisplatin in pediatric patients. | Location Research Triangle Park |
| |
Company Fernel Therapeutics Inc. | Activity: Research and Development | Company Description Fernel Therapeutics develops medical devices and pharmaceuticals for the treatment of benign or non-infectious diseases of the pelvic region. | Location Apex |
| |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh |
| |
Company Focal Medical Inc. | Activity: Research and Development | Company Description Focal Medical develops novel therapeutic products based on its local drug delivery technology platform. | Location Cary |
| |
Company Foundation Medicine Inc. | Activity: Research and Development | Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials. | Location Morrisville |
| |
Company FUJIFILM Diosynth Biotechnologies (Holly Springs) | Activity: Production and Manufacturing | Company Description FUJIFILM Diosynth Biotechnologies Holly Springs site will conduct large-scale cell culture manufacturing of bulk drug substance, as well as provide automated fill-finish and assembly of syringes and equipment for packaging and labeling. | Location Holly Springs |
| |
Company FUJIFILM Diosynth Biotechnologies USA Inc. (Morrisville) | Activity: Production and Manufacturing | Company Description FUJIFILM Diosynth Biotechnologies is a contract development and manufacturing organization for biologics, vaccines, cell and gene therapies, and oncolytic viruses. Services include cell line development, process and analytical development, clinical and commercial manufacturing and bioprocess research and development. | Location Morrisville |
| |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park |
| |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham |
| |
Company Genebiology Inc. | Activity: Research and Development | Company Description GeneBiology identifies, patents and develops new parenteral formulations of approved drugs for unmet medical needs using the 505b2 regulatory pathway. | Location Research Triangle Park |
| |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park |
| |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham |
| |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh |
| |
Company Genoverde Biosciences Inc. | Activity: Research and Development | Company Description Genoverde Biosciences is developing improved varieties of industrial hemp through traditional breeding and genetic engineering technologies for agricultural and biomedical applications. | Location Raleigh |
| |
Company Gilero (Durham) | Activity: Production and Manufacturing | Company Description Gilero provides concept development, prototyping, product/package design, testing/analysis, process development, regulatory and commercialization services in the medical device and drug delivery markets. | Location Durham |
| |
Company Gilero (Pittsboro) | Activity: Production and Manufacturing | Company Description Gilero provides design, development and contract manufacturing services in the medical device and drug delivery markets. The Pittsboro site is a manufacturing facility specializing in device assembly, kitting and packaging services. | Location Pittsboro |
| |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill |
| |
Company Glycan Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Glycan Therapeutics offers solutions for design, synthesis, analysis, and validation of glycosaminoglycans (GAGs), specifically heparan sulfate and chondroitin sulfate. Glycan Therapeutics offers research reagents, analytical and microarray services, and a drug development program. | Location Raleigh |
| |
Company Glycomine Inc. | Activity: Research and Development | Company Description Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding. | Location Chapel Hill |
| |
Company Gradient Medical Inc. | Activity: Research and Development | Company Description Gradient Medical develops interventional oncology therapies to treat primary and metastatic tumors using minimally invasive nanosecond pulsed electric fields. | Location Cary |
| |
Company Green Oil Company LLC | Activity: Production and Manufacturing | Company Description Green Oil processes waste vegetable oil from restaurants to produce fatty acid methyl/ethyl esters for biodiesel and other compounds and additives, plant biomass to produce cannabinoids for health products, biochar and compost for biofiltration, soil amendments and carbon sequestration. | Location Efland |